183 related articles for article (PubMed ID: 6692419)
1. Interactions between 7-hydroxymethotrexate and methotrexate at the cellular level in the Ehrlich ascites tumor in vitro.
Fabre G; Matherly LH; Fabre I; Cano JP; Goldman ID
Cancer Res; 1984 Mar; 44(3):970-5. PubMed ID: 6692419
[TBL] [Abstract][Full Text] [Related]
2. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
Matherly LH; Anderson LA; Goldman ID
Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
[TBL] [Abstract][Full Text] [Related]
3. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high-dose methotrexate-folinic acid "rescue" protocols.
Goldman ID; Gupta V; White JC; Loftfield S
Cancer Res; 1976 Jan; 36(1):276-9. PubMed ID: 1248006
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the formation and membrane transport of 7-hydroxymethotrexate in freshly isolated rabbit hepatocytes.
Fabre G; Fabre I; Gewirtz DA; Goldman ID
Cancer Res; 1985 Mar; 45(3):1086-91. PubMed ID: 2578871
[TBL] [Abstract][Full Text] [Related]
5. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
Matherly LH; Fry DW; Goldman ID
Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
[TBL] [Abstract][Full Text] [Related]
6. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
Fabre G; Goldman ID
Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
[TBL] [Abstract][Full Text] [Related]
7. The issues of transport multiplicity and energetics pertaining to methotrexate efflux in L1210 cells addressed by an analysis of cis and trans effects of inhibitors.
Sirotnak FM; O'Leary DF
Cancer Res; 1991 Mar; 51(5):1412-7. PubMed ID: 1997179
[TBL] [Abstract][Full Text] [Related]
8. Relationship between membrane transport of methotrexate and endogenous cyclic adenosine 3':5'-monophosphate in the Ehrlich ascites tumor.
White JC; Carchman RA; Fry DW; Goldman ID
Cancer Res; 1980 Jul; 40(7):2400-4. PubMed ID: 6155994
[TBL] [Abstract][Full Text] [Related]
9. In vitro approach to 7-hydroxymethotrexate interaction on methotrexate metabolism as tool of pharmacokinetic study.
Fabre G; Cano JP; Catalin J; Just S
Int J Clin Pharmacol Res; 1983; 3(6):475-84. PubMed ID: 6590470
[TBL] [Abstract][Full Text] [Related]
10. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
Jolivet J; Chabner BA
J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
12. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux.
Sirotnak FM; Moccio DM; Young CW
Cancer Res; 1981 Mar; 41(3):966-70. PubMed ID: 7459883
[TBL] [Abstract][Full Text] [Related]
13. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
14. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
[TBL] [Abstract][Full Text] [Related]
15. The relationship among transport, intracellular binding, and inhibition of RNA synthesis by actinomycin D in Ehrlich ascites tumor cells in vitro.
Bowen D; Goldman ID
Cancer Res; 1975 Nov; 35(11 Pt 1):3054-60. PubMed ID: 1182700
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the membrane transport of folates by anions retained in uremia.
Jennette JC; Goldman ID
J Lab Clin Med; 1975 Nov; 86(5):834-43. PubMed ID: 1185041
[TBL] [Abstract][Full Text] [Related]
17. Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro.
Gewirtz DA; Holt SA
Biochem Pharmacol; 1985 Mar; 34(6):747-54. PubMed ID: 3977951
[TBL] [Abstract][Full Text] [Related]
18. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
Chu BC; Fan CC; Howell SB
J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
[TBL] [Abstract][Full Text] [Related]
19. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
Rhee MS; Galivan J; Wright JE; Rosowsky A
Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
Fabre I; Fabre G; Goldman ID
Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
